Abstract
Haemoptysis is a common complication of bronchopulmonary disease in cystic fibrosis, especially in adults with more advanced lung involvement. The choice of treatment depends on the severity of haemoptysis.
Terlipressin administration is one of the conservative measures. We present a case report of an adult cystic fibrosis patient with massive haemoptysis, whose terlipressin treatment was complicated by severe hyponatraemia.
This complication progressed despite fluid restriction and furosemide and natrium chloride administration. It was resolved within two days of terlipressin discontinuation.
No other causes of hyponatraemia were identified. In this paper, attention is drawn to severe hyponatraemia as a rare complication of terlipressin treatment.
Strict monitoring of serum electrolytes and osmolality during treatment with vasopressin analogues is highly recommended.